IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 108 filers reported holding IGM BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $626,250 | -9.5% | 75,000 | 0.0% | 0.01% | -12.5% |
Q2 2023 | $692,250 | -67.2% | 75,000 | -51.2% | 0.01% | -72.4% |
Q1 2023 | $2,113,556 | -17.2% | 153,825 | +2.6% | 0.03% | -14.7% |
Q4 2022 | $2,551,500 | -43.9% | 150,000 | -25.0% | 0.03% | -46.9% |
Q3 2022 | $4,549,000 | +26.1% | 200,047 | 0.0% | 0.06% | +14.3% |
Q2 2022 | $3,607,000 | -66.5% | 200,047 | -50.4% | 0.06% | -68.0% |
Q1 2022 | $10,783,000 | -8.9% | 403,401 | 0.0% | 0.18% | +3.6% |
Q4 2021 | $11,832,000 | -68.4% | 403,401 | -29.1% | 0.17% | -72.3% |
Q3 2021 | $37,418,000 | -39.7% | 569,009 | -23.7% | 0.61% | -47.1% |
Q2 2021 | $62,017,000 | +87.8% | 745,393 | +73.1% | 1.16% | +57.7% |
Q1 2021 | $33,029,000 | -30.8% | 430,683 | -20.3% | 0.73% | -42.1% |
Q4 2020 | $47,713,000 | +615.2% | 540,416 | +498.0% | 1.26% | +477.6% |
Q3 2020 | $6,671,000 | – | 90,378 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |